Future prospects of EGFR-TKIs and surgery for non-small-cell lung cancer

被引：0
|
作者：
Nagano, Tatsuya [1 ]
Tachihara, Motoko [1 ]
Tanaka, Yugo [2 ]
机构：
[1] Kobe Univ, Dept Internal Med, Div Resp Med, Grad Sch Med, Kobe, Hyogo, Japan
[2] Kobe Univ, Div Thorac Surg, Grad Sch Med, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2022年 / 14卷 / 04期
关键词：
OSIMERTINIB;
D O I：
10.21037/jtd-22-57
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：809 / 811
页数：3
相关论文
共 50 条
  • [1] EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance
    Fogli, Stefano
    Polini, Beatrice
    Del Re, Marzia
    Petrini, Iacopo
    Passaro, Antonio
    Crucitta, Stefania
    Rofi, Eleonora
    Danesi, Romano
    PHARMACOGENOMICS, 2018, 19 (08) : 727 - 740
  • [2] AFATINIB IN EGFR MUTANT NON-SMALL-CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO REVERSIBLE EGFR-TKIS
    Cappuzzo, Federico
    Tiseo, Marcello
    Chiari, Rita
    Landi, Lorenza
    Ricciardi, Serena
    Rossi, Elisa
    Galetta, Domenico
    Novello, Silvia
    Milella, Michele
    D'Incecco, Armida
    Haspinger, Eva Regina
    Cortinovis, Diego
    Santo, Antonio
    Banna, Giuseppe
    Facchi-Netti, Francesco
    Levra, Matteo Giaj
    Vari, Sabrina
    Crino, Lucio
    De Marinis, Filippo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S610 - S610
  • [3] The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
    Bai, Hao
    Xiong, Liwen
    Han, Baohui
    ONCOTARGETS AND THERAPY, 2017, 10 : 2335 - 2340
  • [4] HSP70 CAUSES EGFR-TKIS RESISTANCE IN A MUTANT EGFR EXPRESSED NON-SMALL-CELL LUNG CANCER
    Ohmori, T.
    Yamaoka, T.
    Ichihashi, Y.
    Hirose, T.
    Saijo, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 116 - 116
  • [5] The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
    Yu, Xiaoqing
    Si, Jinfei
    Wei, Jingwen
    Wang, Yanling
    Sun, Yan
    Jin, Jianan
    Zhang, Xiaoyan
    Ma, Tonghui
    Song, Zhengbo
    CANCER MEDICINE, 2023, 12 (05): : 5630 - 5638
  • [6] Clinical efficacy and safety of apatinib combined with EGFR-TKIs in advanced non-small cell lung cancer with EGFR-TKIs resistance
    Tian, Ruifen
    Guo, Yi
    Zhang, Xia
    Zhang, Xing
    Guo, Wei
    Zhu, Haibo
    Xu, Junjun
    Shen, Fangfang
    Song, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer
    Wang, Yuyan
    Duan, Jianchun
    Chen, Hanxiao
    Bai, Hua
    An, Tongtong
    Zhao, Jun
    Wang, Zhijie
    Zhuo, Minglei
    Wang, Shuhang
    Wang, Jie
    ONCOLOGY LETTERS, 2017, 13 (04) : 2425 - 2431
  • [8] Clinical Benefit of EGFR-TKIs Plus Radiotherapy for Treating EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer
    Li, T.
    Wang, R.
    Lv, J.
    Sun, C.
    Shi, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E516 - E517
  • [9] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yu, Yinan
    Zhao, Jianguo
    Xu, Jiaona
    Bai, Rui
    Gu, Zewei
    Chen, Xialin
    Wang, Jianfang
    Jin, Xueying
    Gu, Gaoyang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1889 - 1916
  • [10] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yinan Yu
    Jianguo Zhao
    Jiaona Xu
    Rui Bai
    Zewei Gu
    Xialin Chen
    Jianfang Wang
    Xueying Jin
    Gaoyang Gu
    Current Treatment Options in Oncology, 2023, 24 : 1935 - 1947
12345